Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
May 15, 2013
Identification of DNMT1 selective antagonists using a novel scintillation proximity assay
Jessica A Kilgore, Xinlin Du, Lisa Melito, et al.
The European Respiratory Journal
|
September 25, 2020
Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension
David Macias, Stephen Moore, Alexi Crosby, et al.
Structure (London, England : 1993)
|
November 7, 2019
Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820
Xinlin Du, Oleg A Volkov, Robert M Czerwinski, et al.
Nature
|
September 6, 2016
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho, Xinlin Du, James P Rizzi, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Strategic Use of Benzylic Alcohols Reveals Cryptic Hydrogen-Bonding Interactions: Discovery of HBC-12551 as a Potent Noncovalent Bruton's Tyrosine Kinase Inhibitor
Gang Liu, Shuaishuai Liu, Sangwoo Cho, et al.
Cell
|
December 20, 2014
Acetate dependence of tumors
Sarah A Comerford, Zhiguang Huang, Xinlin Du, et al.
Cell
|
May 15, 2012
Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels
Masato Kato, Tina W Han, Shanhai Xie, et al.
Journal of Medicinal Chemistry
|
July 9, 2019
3-[(1<i>S</i>,2<i>S</i>,3<i>R</i>)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
Rui Xu, Keshi Wang, James P Rizzi, et al.
Cancer Research
|
September 17, 2016
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M Wallace, James P Rizzi, Guangzhou Han, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
Paul M Wehn, James P Rizzi, Darryl D Dixon, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
May 15, 2013
Identification of DNMT1 selective antagonists using a novel scintillation proximity assay
Jessica A Kilgore, Xinlin Du, Lisa Melito, et al.
The European Respiratory Journal
|
September 25, 2020
Targeting HIF2α-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension
David Macias, Stephen Moore, Alexi Crosby, et al.
Structure (London, England : 1993)
|
November 7, 2019
Structural Basis and Kinetic Pathway of RBM39 Recruitment to DCAF15 by a Sulfonamide Molecular Glue E7820
Xinlin Du, Oleg A Volkov, Robert M Czerwinski, et al.
Nature
|
September 6, 2016
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models
Hyejin Cho, Xinlin Du, James P Rizzi, et al.
Journal of Medicinal Chemistry
|
January 30, 2026
Strategic Use of Benzylic Alcohols Reveals Cryptic Hydrogen-Bonding Interactions: Discovery of HBC-12551 as a Potent Noncovalent Bruton's Tyrosine Kinase Inhibitor
Gang Liu, Shuaishuai Liu, Sangwoo Cho, et al.
Cell
|
December 20, 2014
Acetate dependence of tumors
Sarah A Comerford, Zhiguang Huang, Xinlin Du, et al.
Cell
|
May 15, 2012
Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels
Masato Kato, Tina W Han, Shanhai Xie, et al.
Journal of Medicinal Chemistry
|
July 9, 2019
3-[(1<i>S</i>,2<i>S</i>,3<i>R</i>)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma
Rui Xu, Keshi Wang, James P Rizzi, et al.
Cancer Research
|
September 17, 2016
A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
Eli M Wallace, James P Rizzi, Guangzhou Han, et al.
Journal of Medicinal Chemistry
|
October 6, 2018
Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate ( S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
Paul M Wehn, James P Rizzi, Darryl D Dixon, et al.
Page
of 2